Kemin announces new director of research and development
New director brings Kemin experience, scientific expertise, and understanding of plant-based molecules to the business unit.
Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, has selected Rebecca Lucas to serve as director of research and development (R&D) for its human nutrition and health business unit.
Lucas previously spent 10 years at Kemin, building expertise in the company and its industries through roles in R&D, marketing and strategic acquisition. Since 2018, she has been with MedPharm Iowa—owned by Kemin President and CEO Dr. Chris Nelson—where she helped launch the state’s first licensed manufacturer of medical cannabis. As technical development manager, Lucas supported a line of 14 products, advocated for legislation that increased patients’ access to medical cannabis, boosted physician and community outreach efforts, and advanced expansion efforts for MedPharm Iowa outside of the state.